Autoimmune Diseases, Healthy, Uveitis
Conditions
Brief summary
The goal of this clinical trial is to learn if dietary supplements containing vitamin and unsaturated fatty acid works to intervene T cell inflammatory factor expression in patients with uveitis and healthy subjects in adults.
Interventions
Vitamin A, 32 microgram per kilograms (of body weight) per day, for three weeks
Monounsaturated fatty acid mixture (mainly Omega-7, Omega-9), 47 milligrams per kilogram (of body weight) per day, for three weeks
Polyunsaturated fatty acid mixture (mainly Omega-3, Omega-6), 6 milligrams per kilogram (of body weight) per day, for three weeks
Fatty acid mixture (mainly saturated fatty acid, Omega-6, Omega-7, Omega-9), 83 milligrams per kilogram (of body weight) per day, for three weeks
Sponsors
Study design
Eligibility
Inclusion criteria
* healthy or with uveitis volunteers age 19-65 years.
Exclusion criteria
* abnormal blood glucose, blood pressure, blood lipids, or other systemic diseases should not participate in the study
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Inflammatory factors-Interferon gamma (IFN-γ) | 3 weeks | Flow cytometry analysis of peripheral blood mononuclear cells (PBMCs) to detect the ratio of Interferon gamma (IFN-γ) -producing cells in CD4+ T cells and CD8+ T cells |
| Inflammatory factors-Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) | 3 weeks | Flow cytometry analysis of peripheral blood mononuclear cells (PBMCs) to detect the ratio of Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) -producing cells in CD4+ T cells and CD8+ T cells |
| Inflammatory factors-Interleukin-17A (IL-17A) | 3 weeks | Flow cytometry analysis of peripheral blood mononuclear cells (PBMCs) to detect the ratio of Interleukin-17A (IL-17A) -producing cells in CD4+ T cells and CD8+ T cells |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Cytokine levels-Interferon gamma (IFN-γ) | 3 weeks | Analysis of cytokine levels in blood. Detect the concention of Interferon gamma (IFN-γ) in plasma |
| Cytokine levels-Interleukin-2 (IL-2) | 3 weeks | Analysis of cytokine levels in blood. Detect the concention of Interleukin-2 (IL-2) in plasma |
| Cytokine levels-Interleukin-17A (IL-17A) | 3 weeks | Analysis of cytokine levels in blood. Detect the concention of Interleukin-17A (IL-17A) in plasma |
| Cytokine levels-Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) | 3 weeks | Analysis of cytokine levels in blood. Detect the concention of Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in plasma |
| Cytokine levels-Interleukin-10 (IL-10) | 3 weeks | Analysis of cytokine levels in blood. Detect the concention of Interleukin-10 (IL-10) in plasma |
| Cytokine levels-Interleukin-9 (IL-9) | 3 weeks | Analysis of cytokine levels in blood. Detect the concention of Interleukin-9 (IL-9) in plasma |
| Cytokine levels-Interleukin-4 (IL-4) | 3 weeks | Analysis of cytokine levels in blood. Detect the concention of Interleukin-4 (IL-4) in plasma |
| Cytokine levels-Tumor Necrosis Factor alpha (TNF-α) | 3 weeks | Analysis of cytokine levels in blood. Detect the concention of Tumor Necrosis Factor alpha (TNF-α) in plasma |
Other
| Measure | Time frame | Description |
|---|---|---|
| Transcriptomics analysis | 3 weeks | Analyze the changes in peripheral blood mononuclear cells using transcriptomics. Detect the cell populations , genes number and expression. |
| Proteomics analysis | 3 weeks | Analyze the changes in peripheral blood mononuclear cells using proteomics. Detect the proteins expression. |
| metabolomics analysis | 3 weeks | Analyze the changes in peripheral blood mononuclear cells using metabolomics. Detect the metabolites numbers, localization and level. |
| post-translational modification proteomics analysis | 3 weeks | Analyze the changes in peripheral blood mononuclear cells using post-translational modification proteomics. Detect the protein various modification, such as lactylation, crotonylation, palmitoylation and methylation. |
Countries
China